BLBalázs Bendegúz Lőrincz

Balázs Bendegúz Lőrincz

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Balázs Bendegúz Lőrincz has a total of 25 co-authors. Here are the top co-authors by number of shared publications:

  • Rainald Knecht

    Universitätsklinikum Hamburg-Eppendorf

    7 shared publications
  • Nikolaus Möckelmann

    Head and Neck Cancer Center of the Hubertus Wald University Cancer Center Hamburg, Department of Otorhinolaryngology, Head and Neck Surgery and Oncology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany

    5 shared publications
  • Chia-Jung Busch

    Head and Neck Cancer Center of the Hubertus Wald University Cancer Center Hamburg, Dept. of Otorhinolaryngology, Head & Neck Surgery and Oncology, University Medical Center Hamburg-Eppendorf, Martinistr. 52, D-20246 Hamburg, Germany

    3 shared publications
  • Susanne Sehner

    Department of Medical Biometry and Epidemiology, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany

    2 shared publications
  • Adrian Muenscher

    University Medical Centre Hamburg-Eppendorf

    1 shared publication
  • Adrian Münscher

    Department of Otorhinolaryngology, Head and Neck Surgery and Oncology, Head and Neck Cancer Centre of the Hubertus Wald University Cancer Centre Hamburg, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany

    1 shared publication

Latest Publications

  • Facial mimetic, cosmetic, and functional standardized assessment of the facial artery musculomucosal (FAMM) flap

    by Nathan Jowett, Tessa A. Hadlock, Eyal Sela, Miklos Toth, Rainald Knecht, Balazs B. Lörincz


  • A nyaki dissectiók onkológiai hozamának maximalizálása a sebészi morbiditás egyidejű minimalizálása mellett

    by István Háromi, Imre Gerlinger, László Lujber, Balázs Bendegúz Lőrincz

    Absztrakt A regionális nyaki lymphadenectomia – elterjedt nevén nyaki dissectio – a fej-nyaki tumorsebészet fontos alapműtéte. Ezen műtét 110 éves evolúciója során a különböző iskolák, nevezéktanok és műtéti technikák keveredése nyomán olyan mértékű zavar alakult ki az irodalomban és a mindennapi szakmai életben, amely szinte lehetetlenné teszi a sebészi és onkológiai eredmények standardizálását és objektív összehasonlítását. Ezt a helyzetet kísérlik meg a szerzők jelen összefoglaló munkájukban közérthetően tisztázni, a multidiszciplináris fej-nyaki terápiás döntésekben részt vevő kollégák kommunikációját megkönnyítendő annak érdekében, hogy a fej-nyaki tumoros betegek számára minden esetben optimális terápiás döntés szülessék. A közlemény történeti és irodalmi áttekintést ad, valamint ismerteti a két legelterjedtebb műtéti technika eredményeinek statisztikai összehasonlítását. A műtéti technika megválasztása szignifikáns hatással van az onkológiai hozamra. A megfelelő sebészi koncepció az onkológiai haszon maximalizálása mellett a betegek életminőségét a lehető legkisebb mértékben befolyásolja, egyrészt a primer sebészi terápiás morbiditás csökkentése, másrészt az adjuváns indikációk optimalizálása révén. Orv. Hetil., 2016, 157(47), 1871–1879. Abstract Cervical regional lymphadenectomy, also known as neck dissection, is a fundamental procedure in head and neck surgery. Its evolution over 110 years resulted in a great deal of confusion in the literature and in clinical practice, due to the heterogenicity in training, classification and surgical techniques, which makes outcomes comparability virtually impossible. The authors aim to clarify this situation in a structured manner, in order to facilitate communication among all specialists involved in multidisciplinary head and neck cancer care. The ultimate goal is to make sure that each and every head and neck cancer patient receives their optimal treatment. Review of the history and literature with statistical comparison of the two mainstraim methods regarding their nodal yield results. The applied surgical technique has a significant impact on nodal yield. An appropriate surgical concept achieves maximum oncologic benefit, minimum surgical morbidity with optimized adjuvant indications. Orv. Hetil., 2016, 157(47), 1871–1879.

  • Neue Aspekte in der Therapie von Schilddrüsenkarzinomen

    by B. B. Lörincz, C. Simon, N. Möckelmann, R. Knecht

  • Robotic-assisted selective and modified radical neck dissection in head and neck cancer patients

    by Nikolaus Möckelmann, Balazs B. Lörincz, Rainald Knecht

    Recently, several authors introduced various methods and published feasibility studies on novel robotic-assisted neck dissection techniques for head and neck cancer patients. Cosmesis and general appearance have become important concerns of cancer patients today. Especially in the head and neck area, a conspicuous scar can reduce patient satisfaction after surgery. With conventional neck dissection techniques, a long scar in the neck is unavoidable. Therefore, the development of robotic assisted neck dissection provides the patients with a scarless neck in these situations. However, there are some limitations of the application of these techniques in their current stage of development. This study was performed using a systematic literature review. The reviewed clinical studies show that robotic-assisted neck dissection yields similar functional and early oncologic outcomes to that of conventional neck dissection, as well as excellent cosmetic satisfaction of patients. Despite these benefits, some disadvantages can be observed, in terms of longer operation times as well as higher procedure costs. Besides the similar oncologic and functional outcomes compared with the open procedure so far, more prospective, controlled, multicenter studies are required to establish robotic-assisted neck dissection as an alternative standard and to justify its added costs beyond the cosmetic advantages.


  • Postoperative antibiotic prophylaxis in clean-contaminated head and neck oncologic surgery: a retrospective cohort study

    by C.-J. Busch, R. Knecht, A. Münscher, J. Matern, C. Dalchow, B. B. Lörincz

    Antibiotic prophylaxis is commonly used in head and neck oncologic surgery, due to the clean-contaminated nature of these procedures. There is a wide variety in the use of prophylactic antibiotics regarding the duration of application and the choice of agent. The purpose of this study was to determine whether short-term or long-term antibiotic prophylaxis has an impact on the development of head and neck surgical wound infection (SWI). Retrospective chart review was carried out in 418 clean-contaminated head and neck surgical oncology cases at our department. More than 50 variables including tumour type and stage, type of surgical treatment, co-morbidities, duration and choice of antibiotic prophylaxis, and the incidence of SWI were analysed. Following descriptive data analysis, Chi square test by Pearson and Fisher’s exact test were used for statistical evaluation. Fifty-eight of the 418 patients (13.9 %) developed SWI. Patients with advanced disease and tracheotomy showed a significantly higher rate of SWI than those with early stage disease and without tracheotomy (p = 0.012 and p = 0.00017, respectively). However, there was no significant difference between the SWI rates in the short term and long term treatment groups (14.6 and 13.2 %, respectively; p = 0.689). Diabetes and body weight were not found to be risk factors for SWI. Long-term antibiotic prophylaxis was not associated with a decrease in SWI in the entire cohort of patients undergoing clean-contaminated major head and neck oncologic surgery. Our data confirmed the extent of surgery and tracheotomy as being risk factors for postoperative SWI.


  • Automatic periodic stimulation of the vagus nerve during single‐incision transaxillary robotic thyroidectomy: Feasibility, safety, and first cases

    by Balazs B. Lörincz, Nikolaus Möckelmann, Chia‐Jung Busch, Markus Hezel, Rainald Knecht

    Background: Automatic periodic stimulation (APS) of the vagus nerve during thyroid surgery may provide the patient with increased safety to prevent impending thermal or stretch‐related injury to the recurrent laryngeal nerve (RLN).Methods: Vagal stimulation would be of particular interest in remote access robotic thyroid surgery, where the RLN may be exposed to more conducted heat because of the exclusive use of the Harmonic scalpel. Using APS, the console surgeon may adjust the dissection technique according to the signal changes to avoid impending thermal damage to the nerve.Results: In 2 transaxillary robotic thyroidectomy cases, we placed the vagus electrode onto the ipsilateral vagus trunk through the single‐incision transaxillary access before docking the da Vinci robot. APS of the ipsilateral nerve has been conducted without complications.Conclusion: APS of the ipsilateral vagus is feasible and safe during transaxillary robotic thyroidectomy, and may contribute to prevent impending thermal injury to the RLN. © 2015 Wiley Periodicals, Inc. Head Neck 38: 482–485, 2016


  • Initial learning curve of single-incision transaxillary robotic hemi- and total thyroidectomy – A single team experience from Europe

    by Balazs B. Lörincz, Chia-Jung Busch, Nikolaus Möckelmann, Rainald Knecht

    The primary advantage of robotic thyroidectomy is to avoid a neck scar. On the other hand, this sophisticated technique implies some potential risks otherwise not associated with conventional thyroidectomy, increased costs, and prolonged operating times. With all these factors being an important issue, we analysed the data of our initial European series in order to understand the nature of the learning curve for this technique. Ten patients underwent transaxillary robotic thyroidectomy for benign disease, performed consistently by the same surgeon with the same team, within a timeframe of 12 months. There were four total thyroidectomies and six hemithyroidectomies. Operating times broken down into creating the working space, docking the robot, and console work (including wound closure), were prospectively recorded and evaluated. By the end of the initial learning curve comprising ten patients, the total operating time for a robotic hemithyroidectomy and for a total thyroidectomy has decreased by 49% to 190 min, and by 31% to 229 min, respectively. Intraoperative complications were successfully managed without conversion to open access surgery. The learning curve for transaxillary robotic thyroidectomy is rather steep; reasonable progress in terms of operating times can be achieved within the first ten cases. Consistency in the team and careful patient selection are paramount factors for success.


  • Two-Year Survival Analysis of 50 Consecutive Head and Neck Cancer Patients Treated with Transoral Robotic Surgery in a Single European Centre

    by Balazs B. Lörincz, Nikolaus Möckelmann, Chia-Jung Busch, Adrian Münscher, Susanne Sehner, Carsten V. Dalchow, Rainald Knecht

    To date, this prospective cohort study is the largest of its kind from a single European academic tertiary care center to report 2-year survival outcomes for head and neck squamous cell carcinoma treated primarily with transoral robotic-assisted resection. Fifty consecutive, appropriately staged patients were enrolled prospectively, and underwent transoral robotic surgery (TORS) between September 2011 and August 2013. Overall, 24 patients had a T1 primary tumor, 23 had a T2 primary tumor, 2 had a T3 primary tumor, and 1 had a T4a primary tumor. Eighteen patients had overall stage I–II disease, and 32 patients had stage III–IV disease. Following transoral robotic resection of their primaries and appropriate neck dissection(s) as indicated, adjuvant treatment could be spared for 20 patients; another 5 patients refused the recommended adjuvant treatment. Seventeen patients received 60 Gy adjuvant radiotherapy and 8 patients underwent 66 Gy adjuvant chemoradiotherapy. At the time of the last follow-up visit (median 27 months), overall survival was 94 %, with two disease-specific deaths and one unrelated death (heart attack). The 2-year disease-free and recurrence-free survival rates were 88 and 80 %, respectively; however, the local recurrence rate was only 10 % after 2 years. Using TORS as their primary modality, 40 % of patients did not need adjuvant treatment and showed similar survival rates to that of conventional surgery or primary chemoradiotherapy. In another 34 % of patients, adjuvant chemotherapy could be spared and adjuvant radiotherapy could be reduced by 10 Gy compared with primary chemoradiotherapy of 70 Gy. Further studies are warranted with respect to long-term survival.